Repligen Corporation (RGEN) Stock Overview
NASDAQ · Healthcare · Medical Instruments & Supplies
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities,…
Source: Yahoo Finance
Sector & Industry
Repligen Corporation operates in the Healthcare sector, within the Medical Instruments & Supplies industry group. It is listed on the NASDAQ exchange.
Repligen Corporation at a Glance
| Company | Repligen Corporation |
| Ticker | RGEN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $167.60 |
| Market cap | $9.46B |
| P/E ratio (trailing) | 226.49 |
| EPS (trailing) | $0.74 |
| 52-week high | $188.73 |
| 52-week low | $100.99 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.05 |
| Return on equity (ROE) | 1.99% |
| Debt-to-equity | 32.72% |
| Average volume | 1.13M |
| Shares outstanding | 56.44M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 2,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Repligen Corporation's current P/E ratio?
- Repligen Corporation (RGEN) has a trailing P/E ratio of 226.49 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Repligen Corporation's market capitalisation?
- Repligen Corporation's market cap is $9.46B based on our latest snapshot. See how it ranks by market cap →
- What is RGEN's 52-week range?
- Over the past 52 weeks, RGEN has traded between $100.99 and $188.73. What does the 52-week range mean? →
- How volatile is Repligen Corporation compared to the market?
- Repligen Corporation has a beta of 1.05, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Repligen Corporation pay a dividend?
- Repligen Corporation does not currently pay a dividend according to our latest data.
- What exchange is RGEN listed on?
- RGEN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Repligen Corporation in?
- Repligen Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →